TCL Archive FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC. March 30, 2001
TCL Archive Surgery Improves Survival For Women With Metastatic Breast Cancer At Diagnosis May 26, 2006
TCL Archive Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program November 29, 2002
TCL Archive FDA Approved More Than 50 New Indications For Cancer In 32 Months, Analysis Finds February 19, 2010
